生髓口服液治疗粒细胞减少症和缺乏症的疗效分析与机理探讨

Discussion on effects of Shengsui oral liquid in treatmetnt of granulocytopenia and agranlocytopoiesis

目的：研究生髓口服液对粒细胞减少症和粒细胞缺乏症的临床疗效及其作用机理。方法：46例粒细胞减少症和粒细胞缺乏症病人(中性粒细胞绝对值＜1．8×109／L～0．5×109／L），随机分成使用生髓口服液的中药组和使用升白细胞西药的对照组。按全国统一标准评定疗效，观察骨髓恢复时间。结果：中药组有效率为91．3％，高于对照组的65．2％，且中药组骨髓造血的恢复时间（X±S）为10.4±1．38天，对照组为24．3±4．99天，经统计学处理差异显著，结论：生髓口服液治疗粒细胞减少症和粒细胞缺乏症疗效不仅高于对照组，而且通过促进骨髓造血功能的恢复使骨髓粒细胞增生达到治疗的目的。

To explore the effects and mechanism of shengsui oral liquid in treatment of granuloculpenia andagranlocytopoiesis. METHODS:46 patients were randomly dividal into two group: taking shengsuioral liquid group (clinical group )and takung increasing leucocyte medicine group (control group). And thenrecovery time of bone marrow was observed.RULTS:the effective rate in clinical group was 91. 3%, It was higher than 65. 2% in coned group. The time of hematological recovery in clinical group was 10.4 ± 1 .38 days (X±S). The control group was 24.3 ±4.99 days. CONCLUSIONS: shengsui oral liquid can increase hematological recovery and promote granulocytopoiesis.